A 36-Month Study on the Cost/Utility of Add-On Omalizumab in Persistent Difficult-to-Treat Atopic Asthma in Italy

By Dal Negro Roberto Walter   Tognella Silvia   Pradelli Lorenzo  

Journal of Asthma, Vol. 49, Iss. 8, 2012-10 ,pp. : 843-848

Informa Healthcare

Access to resources Recommend Favorite

Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab)

By D'Amato Gennaro  

Treatments in Respiratory Medicine, Vol. 5, Iss. 6, 2006-01 ,pp. : 393-398

Adis International

Access to resources Recommend Favorite

Increased Plasma Reactive Oxidant Levels and Their Relationship to Blood Cells, Total IgE, and Allergen-specific IgE Levels in Asthmatic Children

By Heidenfelder Brooke   Johnson Markey   Hudgens Edward   Inmon Jefferson   Hamilton Robert G   Neas Lucas   Gallagher Jane E.  

Journal of Asthma, Vol. 47, Iss. 1, 2010-02 ,pp. : 106-111

Informa Healthcare

Access to resources Recommend Favorite

Increased Plasma Reactive Oxidant Levels and Their Relationship to Blood Cells, Total IgE, and Allergen-specific IgE Levels in Asthmatic Children

By Heidenfelder Brooke   Johnson Markey   Hudgens Edward   Inmon Jefferson   Hamilton Robert   Neas Lucas   Gallagher Jane  

Journal of Asthma, Vol. 46, Iss. 7, 2009-09 ,pp. : 687-691

Informa Healthcare

Access to resources Recommend Favorite

The Predictive Value of IgE as Biomarker in Asthma

By Ahmad Al Obaidi Amina   Mohamed Al Samarai Abdul   Yahya Al Samarai Abdul   Al Janabi Jasim  

Journal of Asthma, Vol. 45, Iss. 8, 2008-10 ,pp. : 654-663

Informa Healthcare

Access to resources Recommend Favorite